Detalles de la búsqueda
1.
Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
Oncologist
; 28(6): 551-e454, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37053467
2.
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Cancer
; 128(10): 2025-2035, 2022 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195274
3.
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
Oncologist
; 27(11): 903-e834, 2022 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36181763
4.
Comparison of Body Fluid Volumes Determined by Kinetic Modeling and by Bioimpedance Spectroscopy.
Blood Purif
; 51(10): 866-874, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35152211
5.
Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 25(3): 208-e417, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162814
6.
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Oncologist
; 25(8): e1146-e1157, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32385918
7.
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.
Oncologist
; 24(11): 1420-e1010, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31332099
8.
Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer.
Oncologist
; 24(8): 1033-e617, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31040252
9.
A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 24(4): 459-e131, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30578309
10.
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
Oncologist
; 24(5): 593-e170, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651400
11.
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
Invest New Drugs
; 37(2): 291-296, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30121935
12.
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Cancer
; 124(3): 606-616, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205286
13.
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
Invest New Drugs
; 36(5): 903-910, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846848
14.
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.
BMC Cancer
; 18(1): 1241, 2018 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537950
15.
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.
Cancer Sci
; 108(1): 116-123, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27783867
16.
Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis.
Allergol Int
; 69(3): 465-467, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067932
17.
Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer.
J Infect Chemother
; 19(2): 202-7, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053498
18.
A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study).
Transl Lung Cancer Res
; 12(8): 1802-1806, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691860
19.
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.
Proteomes
; 11(1)2023 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810562
20.
Changes in blood pressure and arterial stiffness monitored using the cardio-ankle vascular index during hemodialysis.
Front Physiol
; 14: 1133037, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891139